The costs and outcomes of paediatric tuberculosis treatment at primary healthcare clinics in Johannesburg, South Africa

Background. Little up-to-date information is available about the costs of providing drug-susceptible tuberculosis (DS-TB) treatment to paediatric patients in South Africa (SA), nor have actual costs incurred at clinics been compared with costs expected from guidelines.Objectives. To estimate actual and guideline treatment costs by means of a retrospective cohort analysis.Methods. We report patient characteristics, outcomes and treatment costs from a retrospective cohort of paediatric and adolescent (